Operating Segments

9 Months Ended

Sep. 30, 2022

Operating Segments

Operating Segments

Note 10. Operating Segments

The Company maintains two active operating segments: Specialized BioTherapeutics and Public Health Solutions. Each segment includes an element of overhead costs specifically associated with its operations, with its corporate shared services group responsible for support functions generic to both operating segments.

	Three Months Ended
	September 30,
	2022		2021
Revenues
Specialized BioTherapeutics	$	—	$	—
Public Health Solutions		166,140		186,198
Total	$	166,140	$	186,198
Loss from Operations
Specialized BioTherapeutics	$	(1,856,553)	$	(2,034,507)
Public Health Solutions		(9,578)		(160,970)
Corporate		(1,215,113)		(1,169,434)
Total	$	(3,081,244)	$	(3,364,911)
Amortization and Depreciation Expense
Specialized BioTherapeutics	$	2,876	$	1,883
Public Health Solutions		479		314
Corporate		1,438		6,678
Total	$	4,793	$	8,875
Other (Expense) Income, Net
Specialized BioTherapeutics	$	(12,613)	$	(26,123)
Corporate		(215,146)		(196,517)
Total	$	(227,759)	$	(222,640)
Share-Based Compensation
Specialized BioTherapeutics	$	28,343	$	28,506
Public Health Solutions		1,054		6,518
Corporate		41,318		44,697
Total	$	70,715	$	79,721

	Nine Months Ended
	September 30,
	2022		2021
Revenues
Specialized BioTherapeutics	$	—	$	—
Public Health Solutions		582,843		548,615
Total	$	582,843	$	548,615
Loss from Operations
Specialized BioTherapeutics	$	(5,396,630)	$	(4,867,481)
Public Health Solutions		(131,201)		(399,512)
Corporate		(5,141,095)		(3,320,184)
Total	$	(10,668,926)	$	(8,587,177)
Amortization and Depreciation Expense
Specialized BioTherapeutics	$	8,273	$	5,644
Public Health Solutions		1,379		941
Corporate		11,886		20,029
Total	$	21,538	$	26,614
Other (Expense) Income, Net
Specialized BioTherapeutics	$	110,975	$	99,512
Corporate		(641,768)		(224,174)
Total	$	(530,793)	$	(124,662)
Share-Based Compensation
Specialized BioTherapeutics	$	85,190	$	86,816
Public Health Solutions		3,162		20,002
Corporate		132,304		148,329
Total	$	220,656	$	255,147

	As of		As of
	September 30,		December 31,
	2022		2021
Identifiable Assets
Specialized BioTherapeutics	$	121,567	$	128,645
Public Health Solutions		137,910		146,296
Corporate		17,687,896		26,594,986
Total	$	17,947,373	$	26,869,927